Illumina Upgrade to Strong Buy: Earnings Estimate Revisions Drive Change

Wednesday, Dec 3, 2025 1:05 pm ET1min read

Illumina (ILMN) upgraded to Zacks Rank #1 (Strong Buy) due to rising earnings estimates and a positive earnings outlook. The company's genetic testing tools business is expected to drive growth, with an average annual return of +25% for Zacks Rank #1 stocks since 1988. Institutional investors use earnings estimates to calculate fair value, leading to higher or lower stock prices based on revisions.

Illumina Upgrade to Strong Buy: Earnings Estimate Revisions Drive Change

Comments



Add a public comment...
No comments

No comments yet